No abstract available
MeSH terms
-
Alemtuzumab / adverse effects
-
Fibrin Fibrinogen Degradation Products
-
Humans
-
Immunologic Factors
-
Multiple Sclerosis* / drug therapy
-
Multiple Sclerosis, Relapsing-Remitting* / drug therapy
Substances
-
Alemtuzumab
-
fibrin fragment D
-
Fibrin Fibrinogen Degradation Products
-
Immunologic Factors